The Valley Desk

NCT03491683 · Interventional trial

INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM)

Overall registry status Active not recruiting

Phase 1 · Phase 2

Conditions Glioblastoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov